Warhaftig Associates, Inc., has stayed close to its roots as a design firm focusing on compelling ways of communicating complex information, particularly related to access and reimbursement for medicines within an evolving health care landscape.

We develop clear, consistent, and coordinated messages delivered
to all stakeholders — health plans, employers, physician and other health care groups as well as prescribers and patients — to help them align and implement their decisions.

Warhaftig Associates focuses exclusively on access and reimbursement issues and managed health care in the changing landscape of health care delivery in the US.

This sharp focus allows us to concentrate on crafting and presenting actionable messages to the various stakeholders who are not only increasingly responsive to quality affordable outcomes, but also more and more interdependent.

This changing and integrated network requires a mindset that goes beyond pharmaceutical marketing and is sensitive to the emerging trends in health care organization and reimbursement.

We are comfortable with complicated issues and delivery of relevant and useful information that is effectively worded and effectively presented to change behavior using both print and electronic media and supporting personal presentations.

We facilitate decision-making by payers (health plans and employers), by physicians and other health care personnel such as case managers and reimbursement specialists, and even patients. Our expertise includes overcoming disincentives as well as creating incentives appropriate for each of the various stakeholders.

Our communications are based on clear understanding of the principles and issues involved in access and reimbursement, including issues of prior authorization, step edits, co-pay but also pay for performance and value-based benefit design.

Small enough to provide personal attention and be highly responsive to client needs.

Large enough to handle large complex projects in support of the client’s goals and direction.

Innovative enough to handle complex strategic and design problems.

We have experience over more than two decades and in many therapeutic categories from diabetes to multiple sclerosis, with a healthy dose of infectious disease agents.

Warhaftig Associates provides a track record of focusing on these issues and coordinating with other agencies to produce both internal and external communications for clients including Novartis, Pfizer, and Sanofi.

Ongoing collaboration with long-term partners provides analysis of payer issues to develop strategies and tactics for new products in new therapeutic categories or additional entrants to crowded categories.